CDGEMM: Studio sulla malattia celiaca

Benvenuto! CDGEMM sta per Celiac Disease Genomic Environmental Microbiome and Metabolomic Study (Studio Genomico Ambientale Microbiomico e Metabolomico nella Malattia Celiaca) e recluta bambini che hanno un parente di primo grado con celiachia.

Vedi in Italiano
Alphabet blocks spelling out CDGEMMA versatile team of doctors and scientists at the Center for Celiac Research at Massachusetts General Hospital, MassGeneral Hospital for Children, and the Celiac Program at Harvard Medical School created the CDGEMM study to learn more about each of the many factors that contribute to the development of celiac disease. This long-term, multi-center study will follow infants from birth through childhood with visits that can be conducted at your local pediatrician’s office. Infants can even be enrolled before birth! Explore our website to learn more about how you can get involved.

The CDGEMM Study is currently recruiting infants in the womb or aged up to 6 months who have a first-degree relative (parent or sibling) with celiac disease.

Contact Us

For general questions about the CDGEMM study, email CDGEMM@mgh.harvard.edu. To enroll, or inquire about enrollment, please contact a participating center nearest you.

For study updates and more information from the Center for Celiac Research, visit our website, Facebook and Twitter pages! You can also find details about the CDGEMM study on clinicaltrials.gov and on the Partners Healthcare clinical trials registration page.

Interested in sharing information about CDGEMM in your healthcare setting?

This flyer can be posted or distributed freely to any interested care providers or potential participants. Thank you for helping to spread the word about CDGEMM!

Meet the Team

  • Alessio Fasano, MD
  • Maureen Leonard, MD
  • Mark A. Salvatore, MD
  • Martha Pacetti, RN, MSN, CPNP
  • Pam Cureton, RD, LDN
  • Gloria Serena, PhD
  • Tori Kenyon, Research Coordinator

CDGEMM Now

As of November 2018, the CDGEMM Study has enrolled 177 infants in the United States and 162 in Italy, and 28 infants in Spain. Check out our recent newsletters below for additional updates on study progress.

Got Comments? CDGEMM participants and care providers are encouraged to submit comments or concerns about the study through this anonymous portal. We love to hear your feedback!